Compare AER & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AER | WST |
|---|---|---|
| Founded | 1995 | 1923 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.0B | 20.2B |
| IPO Year | 2006 | N/A |
| Metric | AER | WST |
|---|---|---|
| Price | $144.84 | $277.32 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 10 |
| Target Price | $146.29 | ★ $346.78 |
| AVG Volume (30 Days) | ★ 1.5M | 715.4K |
| Earning Date | 10-29-2025 | 02-12-2026 |
| Dividend Yield | ★ 0.74% | 0.32% |
| EPS Growth | ★ 63.90 | 0.17 |
| EPS | ★ 20.89 | 6.75 |
| Revenue | ★ $8,344,637,000.00 | $3,017,900,000.00 |
| Revenue This Year | $4.58 | $7.01 |
| Revenue Next Year | N/A | $6.20 |
| P/E Ratio | ★ $6.95 | $41.10 |
| Revenue Growth | ★ 6.67 | 4.92 |
| 52 Week Low | $85.57 | $187.43 |
| 52 Week High | $146.67 | $348.90 |
| Indicator | AER | WST |
|---|---|---|
| Relative Strength Index (RSI) | 70.93 | 54.34 |
| Support Level | $140.35 | $264.92 |
| Resistance Level | $146.67 | $278.43 |
| Average True Range (ATR) | 2.11 | 6.74 |
| MACD | 0.27 | 0.66 |
| Stochastic Oscillator | 83.43 | 65.94 |
AerCap Holdings NV is an aircraft leasing company. Its activities include leasing, financing, sales, and management of commercial aircraft and engines. It also provides aircraft asset management and corporate services to securitization vehicles, joint ventures, and other third parties.It has one business segment: leasing, financing, sales and management of commercial flight equipment (Commercial Flight Equipment Segment).Through its subsidiary, the group also provides engine leasing, certified aircraft engines, airframes, and engine parts. Its geographical segments include United Kingdom, United States, and Other countries.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.